Sign in

CIK 0001160308

  • Non-accelerated filer
  • Smaller reporting company
Ticker
SVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841318182
Phone
+51 285113796
Business address
6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
Former names
Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
  1. 4 Exercise or conversion Director acquired 10,841 shares (option exercise)
  2. 4 Exercise or conversion Director acquired 10,841 shares (option exercise)
  3. 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
  4. 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
  5. 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
  6. 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
  7. 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
  8. 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
  9. 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
  10. 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
  11. 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
  12. 4 Open-market buy 10% owner bought 333,333 shares at $3.00 ($999,999)
  13. 4 Open-market buy Chief Medical Officer bought 6,500 shares at $2.93 ($19,045)
  14. 4 Open-market buy Director bought 100,000 shares at an average $2.59 ($258,529)
  15. 4 Grant or award Chief Operating Officer acquired 140,000 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy Director bought 36,000 shares at an average $1.54 ($55,586)
  18. 4 Open-market buy Director bought 19,000 shares at an average $1.45 ($27,588)
  19. 4 Open-market buy Chief Medical Officer bought 3,500 shares at $1.54 ($5,402)
  20. 4 Open-market buy Director bought 45,000 shares at an average $1.48 ($66,434)

Page 4 of 22 · 436 filings